ArticleAnnals of surgical oncology2025

Favorable Response Defined by CA19-9 Reduction After Neoadjuvant Treatment for Pancreatic Cancer.

Yuya Ashitomi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.